{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:11:09Z","timestamp":1773450669911,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.maturitas.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T09:02:59Z","timestamp":1367139779000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Diabetes and bone health"],"prefix":"10.1016","volume":"76","author":[{"given":"Marianna","family":"Antonopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl","family":"Bahtiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan S.","family":"Sacerdote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.maturitas.2013.04.004_bib0005","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporosis International"},{"issue":"11","key":"10.1016\/j.maturitas.2013.04.004_bib0010","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/oxfordjournals.aje.a116622","article-title":"Risk factors for hip fracture in middle-aged Norwegian women and men","volume":"137","author":"Meyer","year":"1993","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: a Prospective Study","volume":"86","author":"Schwartz","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1016\/j.maturitas.2013.04.004_bib0020","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","article-title":"Iowa Women's Health Study, Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women","volume":"24","author":"Nicodmus","year":"2001","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.maturitas.2013.04.004_bib0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study","volume":"16","author":"de Liefde","year":"2005","journal-title":"Osteoporosis International"},{"issue":"10","key":"10.1016\/j.maturitas.2013.04.004_bib0030","doi-asserted-by":"crossref","first-page":"M648","DOI":"10.1093\/gerona\/57.10.M648","article-title":"Diabetes mellitus as a risk factor for hip fracture in Mexican American older adults","volume":"57","author":"Ottenbacher","year":"2002","journal-title":"Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"14","key":"10.1016\/j.maturitas.2013.04.004_bib0035","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archinte.165.14.1612","article-title":"Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study","volume":"165","author":"Strotmeyer","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7547\/0980035","article-title":"A comparison of vitamin D levels in nondiabetic and diabetic patient populations","volume":"99","author":"Yoho","year":"2009","journal-title":"Journal of the American Podiatric Medical Association"},{"issue":"4","key":"10.1016\/j.maturitas.2013.04.004_bib0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporosis International"},{"issue":"8","key":"10.1016\/j.maturitas.2013.04.004_bib0050","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/diacare.26.8.2365","article-title":"Does low bone mineral density start in post-teenage years in women with type 1 diabetes?","volume":"26","author":"Liu","year":"2003","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1138\/20090390","article-title":"Advanced glycation end-products and bone fractures","author":"Vashishth","year":"2009","journal-title":"IBMS BoneKEy"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0060","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc06-2003","article-title":"Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program","volume":"30","author":"Herman","year":"2007","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.maturitas.2013.04.004_bib0065","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/jbmr.5650100709","article-title":"Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells","volume":"10","author":"Inaba","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s001980050180","article-title":"Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-Dihydroxyvitamin D3 in Patients with Type 2 Diabetes","volume":"9","author":"Inaba","year":"1999","journal-title":"Osteoporosis International"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00198-008-0763-3","article-title":"Poor glycemic control is associated with low BMD detected in premenopausal women with Type 1 Diabetes","volume":"20","author":"Danielson","year":"2009","journal-title":"Osteoporos International"},{"issue":"2","key":"10.1016\/j.maturitas.2013.04.004_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002239900498","article-title":"Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus","volume":"63","author":"Rosato","year":"1998","journal-title":"Calcified Tissue International"},{"issue":"9","key":"10.1016\/j.maturitas.2013.04.004_bib0085","first-page":"2915","article-title":"Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover","volume":"82","author":"Okazaki","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/j.maturitas.2013.04.004_bib0090","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1359\/jbmr.081234","article-title":"Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men","volume":"24","author":"Kindblom","year":"2009","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/jc.2008-1455","article-title":"Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus","volume":"94","author":"Kanazawa","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.abb.2010.07.030","article-title":"Bone and glucose metabolism: a two-way street","volume":"503","author":"Motyl","year":"2010","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"13","key":"10.1016\/j.maturitas.2013.04.004_bib0105","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.maturitas.2013.04.004_bib0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1464-5491.1993.tb00076.x","article-title":"Calcium metabolism in diabetes mellitus: effect of improved blood glucose control","volume":"10","author":"Thalassinos","year":"1993","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.maturitas.2013.04.004_bib0120","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults","volume":"91","author":"Schwartz","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0125","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","article-title":"The peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial","volume":"92","author":"Grey","year":"2007","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0130","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dc06-2606","article-title":"Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men","volume":"30","author":"Yaturu","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.maturitas.2013.04.004_bib0135","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/joe.1.05723","article-title":"Rosiglitazone impacts negatively on bone by promoting osteoblast\/osteocyte apoptosis","volume":"183","author":"Soroc\u00e9anu","year":"2004","journal-title":"Journal of Endocrinology"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1507\/endocrj.46.795","article-title":"Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus","volume":"46","author":"Okazaki","year":"1999","journal-title":"Endocrine Journal"},{"issue":"9","key":"10.1016\/j.maturitas.2013.04.004_bib0150","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1210\/jc.2007-0431","article-title":"Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women","volume":"92","author":"Berberoglu","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.maturitas.2013.04.004_bib0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s007740300026","article-title":"Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients","volume":"21","author":"Watanabe","year":"2003","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0160","first-page":"37","article-title":"Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women","volume":"81","author":"Raisz","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI118382","article-title":"Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women","volume":"97","author":"Slemenda","year":"1996","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.maturitas.2013.04.004_bib0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0378-5122(84)90002-1","article-title":"Androgen and estrogen dynamics in women with vertebral crush fractures","volume":"6","author":"Longcope","year":"1984","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2004-1649","article-title":"Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors","volume":"147","author":"Singh","year":"2006","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MED.0b013e3283328aee","article-title":"Role of the pituitary-bone axis in skeletal pathophysiology","volume":"16","author":"Imam","year":"2009","journal-title":"Current Opinion in Endocrinology, Diabetes & Obesity"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2008.09.027","article-title":"Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women","volume":"400","author":"Xu","year":"2009","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0190","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/endo.141.11.7765","article-title":"Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice","volume":"141","author":"Danilovich","year":"2000","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.maturitas.2013.04.004_bib0195","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/meta.2003.50028","article-title":"Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone","volume":"52","author":"Vierhapper","year":"2003","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1472-8206.2010.00916.x","article-title":"Pharmacotherapy of polycystic ovary syndrome\u2014an update","volume":"26","author":"Saha","year":"2012","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2007-992786","article-title":"Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells","volume":"116","author":"Schurman","year":"2008","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"issue":"10","key":"10.1016\/j.maturitas.2013.04.004_bib0210","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"10.1016\/j.maturitas.2013.04.004_bib0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejphar.2011.07.033","article-title":"Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats","volume":"668","author":"Sedlinsky","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0220","series-title":"New York Downstate scientific meeting& The 2000 Endocrine Society annual meeting.","article-title":"Do insulin sensitizers repair the gene defect in non-classical adrenal hyperplasia? ACP New York Chapter, 2000","author":"Osehobo","year":"2000"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0225","series-title":"Amenorrhea","first-page":"85","article-title":"Management approaches to congenital adrenal hyperplasia in adolescents and adults; latest therapeutic developments","author":"Bahtiyar","year":"2011"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0230","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4158\/EP.13.6.601","article-title":"Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone","volume":"13","author":"Bahtiyar","year":"2007","journal-title":"Endocrine Practice"},{"issue":"3","key":"10.1016\/j.maturitas.2013.04.004_bib0235","first-page":"145","article-title":"Effects of metformin and short-term lifestyle modification on the improvement of male hypogonadism associated with metabolic syndrome","volume":"35","author":"Casulari","year":"2010","journal-title":"Minerva Endocrinologica"},{"issue":"11","key":"10.1016\/j.maturitas.2013.04.004_bib0240","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1463-1326.2011.01461.x","volume":"13","author":"Borges","year":"2011","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"5","key":"10.1016\/j.maturitas.2013.04.004_bib0245","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00774-010-0160-9","article-title":"Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus","volume":"28","author":"Kanazawa","year":"2010","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0250","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/dc11-1099","article-title":"Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials","volume":"34","author":"Monami","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0255","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/152091599316775","article-title":"Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility","volume":"2","author":"Thrailkill","year":"2000","journal-title":"Diabetes Technology & Therapeutics"},{"issue":"3","key":"10.1016\/j.maturitas.2013.04.004_bib0265","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1677\/joe.0.1340485","article-title":"The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats","volume":"134","author":"Verhaeghe","year":"1992","journal-title":"Journal of Endocrinology"},{"issue":"12","key":"10.1016\/j.maturitas.2013.04.004_bib0270","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00198-007-0430-0","article-title":"Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus","volume":"18","author":"Kanazawa","year":"2007","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0275","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jbmr.5650110916","article-title":"Insulin receptor expression in bone","volume":"11","author":"Thomas","year":"1996","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0280","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.maturitas.2013.04.004_bib0285","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2337\/dc06-1851","article-title":"The risk of hip fractures in older individuals with diabetes","volume":"30","author":"Lipscombe","year":"2007","journal-title":"Diabetes Care"},{"issue":"70","key":"10.1016\/j.maturitas.2013.04.004_bib0290","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/dc11-2184","article-title":"Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial","volume":"35","author":"Schwartz","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.maturitas.2013.04.004_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-115-1-1","article-title":"Diuretic drug use and the risk for hip fracture","volume":"115","author":"Heidrich","year":"1991","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1016\/j.maturitas.2013.04.004_bib0300","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/0003-4819-118-9-199305010-00002","article-title":"Effects of thiazide diuretic therapy on bone mass, fractures, and falls, The Study of Osteoporotic Fractures Research Group","volume":"118","author":"Cauley","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1016\/j.maturitas.2013.04.004_bib0305","article-title":"Thiazide diuretics and the risk of hip fracture","author":"Aung","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1016\/j.maturitas.2013.04.004_bib0310","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/oxfordjournals.aje.a116954","article-title":"Thiazides and bone mineral density in elderly men and women","volume":"139","author":"Morton","year":"1994","journal-title":"American Journal of Epidemiology"},{"issue":"7","key":"10.1016\/j.maturitas.2013.04.004_bib0315","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.168.7.735","article-title":"Loop diuretic use and increased rates of hip bone loss in older men: The Osteoporotic Fractures in Men Study","volume":"168","author":"Lim","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0320","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jbmr.5650080604","article-title":"Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women","volume":"8","author":"Ooms","year":"1993","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"10.1016\/j.maturitas.2013.04.004_bib0325","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"issue":"6","key":"10.1016\/j.maturitas.2013.04.004_bib0330","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bone.2004.02.002","article-title":"Ex vivo bone mineral density of the wrist: influence of medullar fat","volume":"34","author":"Chappard","year":"2004","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.maturitas.2013.04.004_bib0335","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jc.2007-1270","article-title":"Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes","volume":"93","author":"Yamamoto","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1016\/j.maturitas.2013.04.004_bib0340","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.metabol.2009.11.017","article-title":"Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus","volume":"59","author":"Kanazawa","year":"2010","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"9","key":"10.1016\/j.maturitas.2013.04.004_bib0345","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-118-9-199305010-00001","article-title":"Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group","volume":"118","author":"Bauer","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.maturitas.2013.04.004_bib0350","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2174\/138945011798829456","article-title":"Role of advanced glycation end products (AGEs) in osteoporosis in diabetes","volume":"12","author":"Yamagishi","year":"2011","journal-title":"Current Drug Targets"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512213001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512213001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:58:00Z","timestamp":1759913880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512213001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0378512213001096"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2013.04.004","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and bone health","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2013.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}